In 842 adults with episodic migraine in Germany, the sinCephalea app giving personalised low-glycaemic diet advice with intermittent glucose monitoring cut monthly migraine days more than a control app at 12 weeks (−1.7 vs −1.2; difference −0.53 days), open-label.
RCTn = 842
Evers et al. Efficacy of digital therapeutic sinCephalea for personalised nutrition versus control for migraine prevention: A 12-week open-label randomised clinical trial